Worldwide trends in the burden of asthma symptoms in school-aged children: Global Asthma Network Phase I cross-sectional study

An enhanced care package to improve asthma management in Malawian children: a randomised controlled trial

(2021) Sarah Rylance et al.   THORAX

Improving lung health in low-income and middle-income countries: from challenges to solutions

(2021) Jamilah Meghji et al.   LANCET

“Trends in worldwide asthma prevalence”

(2020) M. Innes Asher et al.   EUROPEAN RESPIRATORY JOURNAL

Global Asthma Network Phase I Surveillance: Geographical Coverage and Response Rates

(2020) Philippa Ellwood et al.   Journal of Clinical Medicine

Combined impact of healthy lifestyle factors on risk of asthma, rhinoconjunctivitis and eczema in school children: ISAAC phase III

(2019) Eva Morales et al.   THORAX

Are environmental risk factors for current wheeze in the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three due to reverse causation?

(2018) Richard J Silverwood et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

(2018) Spencer L James et al.   LANCET

Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

(2018) Hmwe Hmwe Kyu et al.   LANCET

Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017

(2018) Gregory A Roth et al.   LANCET

Calling time on asthma deaths in tropical regions—how much longer must people wait for essential medicines?

(2018) Innes Asher et al.   Lancet Respiratory Medicine

Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

(2017) Theo Vos et al.   LANCET

The Global Asthma Network rationale and methods for Phase I global surveillance: prevalence, severity, management and risk factors

(2016) Philippa Ellwood et al.   EUROPEAN RESPIRATORY JOURNAL

Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015

(2016) Theo Vos et al.   LANCET

Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

(2015) Theo Vos et al.   LANCET

The challenges of replicating the methodology between Phases I and III of the ISAAC programme

(2012) P. Ellwood et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

(2012) Theo Vos et al.   LANCET

Global variation in the prevalence and severity of asthma symptoms: Phase Three of the International Study of Asthma and Allergies in Childhood (ISAAC)

(2009) C K W Lai et al.   THORAX